{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T19:59:17Z","timestamp":1773259157629,"version":"3.50.1"},"reference-count":58,"publisher":"American Association for Cancer Research (AACR)","issue":"4","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background: Metabolic dysregulation has been identified as an \u201cemerging hallmark\u201d of cancer. The heterotrimeric AMP-activated protein kinase (AMPK) complex is a central regulator of the metabolic system and an important component of the mTOR pathway and the p53 axis, making it uniquely positioned to influence carcinogenesis through its canonical functions in the metabolic arena, as well as through more traditional mechanisms such as regulation of apoptosis and angiogenesis.<\/jats:p>\n                  <jats:p>Methods: We conducted a population-based genetic association study to examine the impact of mutations in AMPK subunit genes on risk of non\u2013Hodgkin lymphoma (NHL). We also analyzed public microarray data to determine the expression of AMPK in NHL cells and to assess the influence of AMPK expression on overall survival in patients with NHL.<\/jats:p>\n                  <jats:p>Results: We identified an AMPK subunit haplotype, which was significantly associated with NHL [OR, 5.44, 95% confidence interval (CI), 2.15\u201313.75] in women with no family history of cancer. Haplotypes in two subunits, PRKAA2 and PRKAG3, were nominally associated with the follicular and diffuse large B-cell lymphoma histologic subtypes, respectively, although these associations did not retain statistical significance after correction for multiple comparisons. Further, both of these subunits were differentially expressed (P &amp;lt; 0.05) in one or more lymphoma cell type, and higher expression of two versions of the AMPK-\u03b2 subunit was significantly associated with increased 5-year survival among patients with NHL (P = 0.001 and P = 0.021).<\/jats:p>\n                  <jats:p>Conclusion: These results provide evidence for AMPK involvement in the pathogenesis and progression of NHL.<\/jats:p>\n                  <jats:p>Impact: These findings may lead to a novel area of research into NHL treatment and chemoprevention. Cancer Epidemiol Biomarkers Prev; 22(4); 736\u201344. \u00a92013 AACR.<\/jats:p>","DOI":"10.1158\/1055-9965.epi-12-1014","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T22:57:32Z","timestamp":1360364252000},"page":"736-744","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association of AMP-Activated Protein Kinase with Risk and Progression of Non\u2013Hodgkin Lymphoma"],"prefix":"10.1158","volume":"22","author":[{"given":"Aaron E.","family":"Hoffman","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Epidemiology, Tulane School of Public Health and Tropical Medicine and Tulane Cancer Center, New Orleans, Louisiana; and 2Department of Environmental Health Sciences, Yale University School of Public Health, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Demanelis","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Epidemiology, Tulane School of Public Health and Tropical Medicine and Tulane Cancer Center, New Orleans, Louisiana; and 2Department of Environmental Health Sciences, Yale University School of Public Health, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Fu","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Epidemiology, Tulane School of Public Health and Tropical Medicine and Tulane Cancer Center, New Orleans, Louisiana; and 2Department of Environmental Health Sciences, Yale University School of Public Health, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongzhang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Epidemiology, Tulane School of Public Health and Tropical Medicine and Tulane Cancer Center, New Orleans, Louisiana; and 2Department of Environmental Health Sciences, Yale University School of Public Health, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Epidemiology, Tulane School of Public Health and Tropical Medicine and Tulane Cancer Center, New Orleans, Louisiana; and 2Department of Environmental Health Sciences, Yale University School of Public Health, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2013,4,2]]},"reference":[{"key":"2022060920280253200_bib1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/bj3460659","article-title":"Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding","volume":"346","author":"Cheung","year":"2000","journal-title":"Biochem J"},{"key":"2022060920280253200_bib2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/iub.387","article-title":"Metabolic functions of AMPK: aspects of structure and of natural mutations in the regulatory gamma subunits","volume":"62","author":"Moffat","year":"2010","journal-title":"IUBMB Life"},{"key":"2022060920280253200_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-5793(87)80292-2","article-title":"A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis","volume":"223","author":"Carling","year":"1987","journal-title":"FEBS Lett"},{"key":"2022060920280253200_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.75.103004.142702","article-title":"LKB1-dependent signaling pathways","volume":"75","author":"Alessi","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"2022060920280253200_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tem.2006.05.006","article-title":"Expanding role of AMPK in endocrinology","volume":"17","author":"Kola","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"2022060920280253200_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2004.06.007","article-title":"The LKB1 tumor suppressor negatively regulates mTOR signaling","volume":"6","author":"Shaw","year":"2004","journal-title":"Cancer Cell"},{"key":"2022060920280253200_bib7","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1038\/onc.2010.630","article-title":"The long and winding road to rational treatment of cancer associated with LKB1\/AMPK\/TSC\/mTORC1 signaling","volume":"30","author":"van Veelen","year":"2011","journal-title":"Oncogene"},{"key":"2022060920280253200_bib8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ncb999","article-title":"Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins","volume":"5","author":"Zhang","year":"2003","journal-title":"Nat Cell Biol"},{"key":"2022060920280253200_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"key":"2022060920280253200_bib10","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1128\/MCB.22.20.7004-7014.2002","article-title":"Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin","volume":"22","author":"Hudson","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2022060920280253200_bib11","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1091\/mbc.e08-12-1249","article-title":"ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery","volume":"20","author":"Jung","year":"2009","journal-title":"Mol Biol Cell"},{"key":"2022060920280253200_bib12","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s00018-006-6080-0","article-title":"Peutz-Jeghers syndrome: clinicopathology and molecular alterations","volume":"63","author":"McGarrity","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"2022060920280253200_bib13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"2022060920280253200_bib14","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejca.2005.03.023","article-title":"Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes","volume":"41","author":"Jiang","year":"2005","journal-title":"Eur J Cancer"},{"key":"2022060920280253200_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","article-title":"AMP-activated protein kinase induces a p53-dependent metabolic checkpoint","volume":"18","author":"Jones","year":"2005","journal-title":"Mol Cell"},{"key":"2022060920280253200_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/aje\/kwh233","article-title":"Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut women","volume":"160","author":"Zhang","year":"2004","journal-title":"Am J Epidemiol"},{"key":"2022060920280253200_bib17","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/ng1669","article-title":"Efficiency and power in genetic association studies","volume":"37","author":"de Bakker","year":"2005","journal-title":"Nat Genet"},{"key":"2022060920280253200_bib18","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20080809","article-title":"Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis","volume":"205","author":"Brune","year":"2008","journal-title":"J Exp Med"},{"key":"2022060920280253200_bib19","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"key":"2022060920280253200_bib20","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"key":"2022060920280253200_bib21","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/leu.2008.188","article-title":"The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab","volume":"22","author":"Jais","year":"2008","journal-title":"Leukemia"},{"key":"2022060920280253200_bib22","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"key":"2022060920280253200_bib23","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1182\/blood-2010-05-285320","article-title":"DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma","volume":"116","author":"Shaknovich","year":"2010","journal-title":"Blood"},{"key":"2022060920280253200_bib24","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/379378","article-title":"A comparison of Bayesian methods for haplotype reconstruction from population genotype data","volume":"73","author":"Stephens","year":"2003","journal-title":"Am J Hum Genet"},{"key":"2022060920280253200_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate - a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Roy Stat Soc B Met"},{"key":"2022060920280253200_bib26","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gkr917","article-title":"HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants","volume":"40","author":"Ward","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2022060920280253200_bib27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2012.09.017","article-title":"Cancer genetics and genomics of human FOX family genes","volume":"328","author":"Katoh","year":"2013","journal-title":"Cancer Lett"},{"key":"2022060920280253200_bib28","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1182\/blood-2004-03-1209","article-title":"Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome","volume":"104","author":"Barrans","year":"2004","journal-title":"Blood"},{"key":"2022060920280253200_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/bjs.5673","article-title":"MicroRNAs and cancer","volume":"94","author":"Wijnhoven","year":"2007","journal-title":"Br J Surg"},{"key":"2022060920280253200_bib30","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/carcin\/bgq142","article-title":"Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1","volume":"31","author":"Slattery","year":"2010","journal-title":"Carcinogenesis"},{"key":"2022060920280253200_bib31","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10549-010-1269-1","article-title":"Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC)","volume":"127","author":"Campa","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"2022060920280253200_bib32","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.2337\/db10-0543","article-title":"Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program","volume":"59","author":"Jablonski","year":"2010","journal-title":"Diabetes"},{"key":"2022060920280253200_bib33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/EJE-09-0245","article-title":"Association study of AMP-activated protein kinase subunit genes in polycystic ovary syndrome","volume":"161","author":"Sproul","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2022060920280253200_bib34","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1182\/blood-2006-05-026203","article-title":"Syk-dependent mTOR activation in follicular lymphoma cells","volume":"108","author":"Leseux","year":"2006","journal-title":"Blood"},{"key":"2022060920280253200_bib35","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.2353\/ajpath.2006.051078","article-title":"Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma","volume":"169","author":"Peponi","year":"2006","journal-title":"Am J Pathol"},{"key":"2022060920280253200_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.leu.2404471","article-title":"Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma","volume":"21","author":"Haritunians","year":"2007","journal-title":"Leukemia"},{"key":"2022060920280253200_bib37","first-page":"1433","article-title":"Inhibition of the mammalian target of rapamycin and the induction of cell cycle arrest in mantle cell lymphoma cells","volume":"90","author":"Hipp","year":"2005","journal-title":"Haematologica"},{"key":"2022060920280253200_bib38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood-2002-01-0189","article-title":"Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin","volume":"101","author":"Decker","year":"2003","journal-title":"Blood"},{"key":"2022060920280253200_bib39","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1182\/blood-2010-05-283960","article-title":"AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells","volume":"116","author":"Santidrian","year":"2010","journal-title":"Blood"},{"key":"2022060920280253200_bib40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2141.2006.06210.x","article-title":"Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab","volume":"134","author":"Wanner","year":"2006","journal-title":"Br J Haematol"},{"key":"2022060920280253200_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/leu.2010.226","article-title":"A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma","volume":"25","author":"Witzig","year":"2011","journal-title":"Leukemia"},{"key":"2022060920280253200_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ccr.2012.07.014","article-title":"Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma","volume":"22","author":"Monti","year":"2012","journal-title":"Cancer Cell"},{"key":"2022060920280253200_bib43","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.emboj.7600110","article-title":"LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK\/PAR-1","volume":"23","author":"Lizcano","year":"2004","journal-title":"EMBO J"},{"key":"2022060920280253200_bib44","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.molcel.2010.08.019","article-title":"AID-induced genotoxic stress promotes B cell differentiation in the germinal center via ATM and LKB1 signaling","volume":"39","author":"Sherman","year":"2010","journal-title":"Mol Cell"},{"key":"2022060920280253200_bib45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.RES.0000256090.42690.05","article-title":"AMP-activated protein kinase in metabolic control and insulin signaling","volume":"100","author":"Towler","year":"2007","journal-title":"Circ Res"},{"key":"2022060920280253200_bib46","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1432-1033.1995.tb20498.x","article-title":"5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?","volume":"229","author":"Corton","year":"1995","journal-title":"Eur J Biochem"},{"key":"2022060920280253200_bib47","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-06-4447","article-title":"Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth","volume":"67","author":"Buzzai","year":"2007","journal-title":"Cancer Res"},{"key":"2022060920280253200_bib48","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prev Res"},{"key":"2022060920280253200_bib49","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3109\/10428194.2011.574752","article-title":"Effect of concomitant statin, metformin, or aspirin on rituximab treatment for diffuse large B-cell lymphoma","volume":"52","author":"Xuan Koo","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"2022060920280253200_bib50","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10637-010-9570-8","article-title":"A phase I study of temsirolimus and metformin in advanced solid tumours","volume":"30","author":"Mackenzie","year":"2012","journal-title":"Invest New Drugs"},{"key":"2022060920280253200_bib51","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1182\/blood-2002-07-2339","article-title":"Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes","volume":"101","author":"Campas","year":"2003","journal-title":"Blood"},{"key":"2022060920280253200_bib52","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.leu.2403593","article-title":"Acadesine induces apoptosis in B cells from mantle cell lymphoma and splenic marginal zone lymphoma","volume":"19","author":"Campas","year":"2005","journal-title":"Leukemia"},{"key":"2022060920280253200_bib53","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander","year":"2009","journal-title":"Science"},{"key":"2022060920280253200_bib54","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1038\/sj.onc.1205737","article-title":"Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation","volume":"21","author":"Kato","year":"2002","journal-title":"Oncogene"},{"key":"2022060920280253200_bib55","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1128\/MCB.00166-06","article-title":"5\u2032-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments","volume":"26","author":"Laderoute","year":"2006","journal-title":"Mol Cell Biol"},{"key":"2022060920280253200_bib56","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3324\/haematol.2011.059246","article-title":"Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response","volume":"97","author":"Jager","year":"2012","journal-title":"Haematologica"},{"key":"2022060920280253200_bib57","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0609.2010.01541.x","article-title":"Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy","volume":"86","author":"Riihijarvi","year":"2011","journal-title":"Eur J Haematol"},{"key":"2022060920280253200_bib58","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"}],"container-title":["Cancer Epidemiology, Biomarkers &amp; Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cebp\/article-pdf\/22\/4\/736\/2277774\/736.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cebp\/article-pdf\/22\/4\/736\/2277774\/736.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T15:19:35Z","timestamp":1714922375000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cebp\/article\/22\/4\/736\/69793\/Association-of-AMP-Activated-Protein-Kinase-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,2]]},"published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1055-9965.epi-12-1014","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1055-9965.c.6515305","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1055-9965.c.6515305.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/1055-9965.22436269","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1055-9965.22436269.v1","asserted-by":"object"}]},"ISSN":["1055-9965","1538-7755"],"issn-type":[{"value":"1055-9965","type":"print"},{"value":"1538-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,1]]}}}